PodcastIntel
Sign in Get Started Free
Life Science Connect

Getting To A First Product Approval With Celcuity's Brian Sullivan

Aug 17, 2026 · 0:50:20
Listen to Episode
✨ AI Summary
  • Brian Sullivan shares Celcuity's first FDA approval for Revtorpyk.
  • Targeting 'untreated disease mechanisms' is a successful strategy.
  • Discusses licensing, trial design, and regulatory review benefits.

Guests on This Episode

BS
Brian Sullivan
English association football player · 2 podcast appearances
›

More from Life Science Connect

Reimagining Solid Tumor Immunotherapy Through Engineered Tregs with CoRegen's Dr. Sonal Gupta
Aug 13, 2026 · 0:16:22
Fixing AAV Recovery With Siren Biotechnology’s Nathalie Clément, Ph.D.
Aug 12, 2026 · 0:48:16
Cell Therapy Advances And Biotech Leadership With Nkarta's Paul Hastings
Aug 10, 2026 · 0:50:30
A Rescue Model For Shelved Drug Candidates With Annette Bakker, Ph.D. And Andrew Lo, Ph.D.
Aug 3, 2026 · 0:55:47
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Life Science Connect and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →